Open·Ingested 90 days ago, not re-verified since

DoW Lung Cancer Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: May 5, 2026
Amount: $9,100,000
Closes: Sep 2, 2026 (in 30 days)

Similar opportunities open now

DoW Lung Cancer Patient-Centered Outcomes and Survivorship AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 30 days
DoW Lung Cancer Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 30 days
DoW Toxic Exposures Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Vision, Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Breast Cancer, Transformative Breast Cancer Consortium AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 58 days

Classification and identifiers

Solicitation number: HT942526LCRPTRA
Assistance listing (CFDA): 12.420

Amount

$9,100,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.